These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 3898283)
1. In vitro influence of thymopentin on proliferative responses and phytohemagglutinin-induced interleukin 2 production in normal human lymphocyte cultures. Duchateau J; Servais G; Cooman R; Collet H; Bolla K Surv Immunol Res; 1985; 4 Suppl 1():116-24. PubMed ID: 3898283 [TBL] [Abstract][Full Text] [Related]
2. In vivo immunopotentiating activity of thymopentin in aging humans: increase of IL-2 production. Meroni PL; Barcellini W; Frasca D; Sguotti C; Borghi MO; De Bartolo G; Doria G; Zanussi C Clin Immunol Immunopathol; 1987 Feb; 42(2):151-9. PubMed ID: 3542319 [TBL] [Abstract][Full Text] [Related]
3. Immunomodulation with thymopentin: in vitro studies. Duchateau J; Bolla K Med Oncol Tumor Pharmacother; 1989; 6(1):19-23. PubMed ID: 2657246 [TBL] [Abstract][Full Text] [Related]
4. In vitro effects of thymopentin on the gamma-interferon production by peripheral blood mononuclear cells from normal subjects and from patients with rheumatoid arthritis. Malaise MG; Bastings M; Reuter AM; Vrindts-Gevaert Y; Bernier J; Sondag D; Frère MC; Goldstein G; Franchimont P Immunol Lett; 1987 Aug; 15(4):323-7. PubMed ID: 3121499 [TBL] [Abstract][Full Text] [Related]
5. [Stimulation of immunogenesis by neurotensin, pentagastrin and thymopentin and ways of its realization]. Belokrylov GA; Molchanova IV; Popova OIa Biull Eksp Biol Med; 1989 Nov; 108(11):584-7. PubMed ID: 2699257 [TBL] [Abstract][Full Text] [Related]
6. Effects of a synthetic extract (thymopentin) on the immune system of lepromatous leprosy patients. Munno I; Pellegrino NM; Fumo G; Barbieri G; Polimeno G; de Filippis V; Jirillo E Cytobios; 1987; 52(210-211):167-73. PubMed ID: 3123147 [TBL] [Abstract][Full Text] [Related]
7. Restoration of the impaired lymphocyte stimulation in old people by thymopoietin pentapeptide. Verhaegen H; De Cock W; De Cree J; Goldstein G J Clin Lab Immunol; 1981 Sep; 6(2):103-5. PubMed ID: 7026790 [TBL] [Abstract][Full Text] [Related]
8. Thymopentin as adjuvant in non-responders or hyporesponders to hepatitis B vaccination. Záruba K; Rastorfer M; Grob PJ; Joller-Jemelka H; Bolla K Lancet; 1983 Nov; 2(8361):1245. PubMed ID: 6139582 [No Abstract] [Full Text] [Related]
9. Experiences with immunomodulant agents in HIV infections. Lazzarin A; Barcellini W; Uberti Foppa C; Borghi MO; Franzetti R; Cinque P; Moroni M Acta Haematol; 1987; 78 Suppl 1():84-90. PubMed ID: 3124453 [TBL] [Abstract][Full Text] [Related]
10. Modulation of immune response in aged humans through different administration modes of thymopentin. Duchateau J; Servais G; Vreyens R; Delespesse G; Bolla K Surv Immunol Res; 1985; 4 Suppl 1():94-101. PubMed ID: 3898299 [TBL] [Abstract][Full Text] [Related]
11. Immunomodulation with thymopentin in humans. Bolla K; Duchateau J; Delespesse G; Servais G Int J Clin Pharmacol Res; 1984; 4(6):431-8. PubMed ID: 6398312 [TBL] [Abstract][Full Text] [Related]
12. In vivo immunopotentiating activity of thymopentin in aging humans: modulation of IL-2 receptor expression. Barcellini W; Meroni PL; Borghi MO; Frasca D; Perego R; Doria G; Zanussi C Clin Immunol Immunopathol; 1988 Aug; 48(2):140-9. PubMed ID: 3134150 [TBL] [Abstract][Full Text] [Related]
13. Influence of thymic hormones on mitogen-induced interferon production in lymphocytes. II. Enhancement of Con-A-induced immune interferon production by a synthetic thymopoietin pentapeptide. Rentz E; Diezel W; Ehrlich A; Forner K Arch Geschwulstforsch; 1984; 54(2):113-8. PubMed ID: 6329122 [TBL] [Abstract][Full Text] [Related]
14. Thymopentin treatment in AIDS and pre-AIDS patients. Clumeck N; Cran S; Van de Perre P; Mascart-Lemone F; Duchateau J; Bolla K Surv Immunol Res; 1985; 4 Suppl 1():58-62. PubMed ID: 3898293 [TBL] [Abstract][Full Text] [Related]
15. Influence of thymopentin on antibody response, and monocyte and T cell function in hemodialysis patients who fail to respond to hepatitis B vaccination. Dumann H; Meuer SC; Renschin G; Köhler H Nephron; 1990; 55(2):136-40. PubMed ID: 2194133 [TBL] [Abstract][Full Text] [Related]
16. The immune-enhancing effect of perioperative thymopentin administration in elderly patients undergoing major surgery. Faist E; Ertel W; Salmen B; Weiler A; Ressel C; Bolla K; Heberer G Arch Surg; 1988 Dec; 123(12):1449-53. PubMed ID: 3056331 [TBL] [Abstract][Full Text] [Related]
17. The effect of thymopentin treatment on the relapse rate in frequently relapsing herpes simplex virus infections. Haneke E; Bolla K; Degreef H; Djawari D; Demaubeuge J; Molin L; Panconesi E; Schöpf E; Stengel R; Stingl G Int J Clin Pharmacol Res; 1984; 4(6):439-43. PubMed ID: 6085327 [TBL] [Abstract][Full Text] [Related]
18. Immunologic effects of long-term thymopentin treatment in patients with HIV-induced lymphadenopathy syndrome. Silvestris F; Gernone A; Frassanito MA; Dammacco F J Lab Clin Med; 1989 Feb; 113(2):139-44. PubMed ID: 2644387 [TBL] [Abstract][Full Text] [Related]
19. Effect of subcutaneous thymopentin treatment in drug addicts with persistent generalized lymphadenopathy. Barcellini W; Meroni PL; Frasca D; Sguotti C; Borghi MO; Uberti-Foppa C; Buzzetti P; Lazzarin A; Doria G; Moroni M Clin Exp Immunol; 1987 Mar; 67(3):537-43. PubMed ID: 3301099 [TBL] [Abstract][Full Text] [Related]
20. Induction and augmentation of mitogen-induced immune interferon production in human lymphocytes by a synthetic thymopoietin pentapeptide. Diezel W; Waschke SR; Forner K Biomed Biochim Acta; 1984; 43(6):K9-12. PubMed ID: 6435610 [No Abstract] [Full Text] [Related] [Next] [New Search]